Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease

Brain Research

Volumn 1297, Issue , 2009, Pages 17-22

  Kaur, Deepinder ^a   Rajagopalan, Subramanian ^a   Andersen, Julie K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Ferritin; Iron; Labile iron pool; Neurodegeneration; Parkinson's disease; Synaptosomes

Indexed keywords

CLIOQUINOL; FERRITIN; IRON; LABILE IRON POOL; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NERVE DEGENERATION; NERVE ENDING; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

AGING; ANIMALS; APOFERRITINS; CHELATING AGENTS; CLIOQUINOL; DOPAMINE; GENE EXPRESSION REGULATION; IRON; IRON METABOLISM DISORDERS; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; SUBSTANTIA NIGRA;

ANIMALIA; MUS;

EID: 71749114332     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.08.043     Document Type: Article

References (35)

1. Arosio P., and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33 (2002) 457-463
2. Bush A.I. Metals and neuroscience. Curr. Opin. Chem. Biol. 4 (2000) 184-191
3. Carmona A., et al. Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques. Anal. Bioanal. Chem 390 (2008) 1585-1594
4. Chinta S.J., et al. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J. Neurosci. 27 (2007) 13997-14006
5. Comporti M. Introduction-serial review: iron and cellular redox status. Free Radic. Biol. Med. 34 (2002) 565-567
6. Double K.L., et al. In vitro studies of ferritin iron release and neurotoxicity. J. Neurochem. 70 (1998) 2492-2499
7. Eisenstein R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 20 (2000) 627-662
8. Epsztejn S., et al. Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248 (1997) 31-40
9. Friedman A., et al. Iron and ferritin in hippocampal cortex and substantia nigra in human brain-implications for the possible role of iron in dementia. J. Neurol. Sci. 248 (2006) 31-34
10. Galaris D., and Pantopoulos K. Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit. Rev. Clin. Lab. Sci. 45 (2008) 1-23
11. Gerlach M., et al. Iron in the Parkinsonian substantia nigra. Mov. Disord. 12 (1997) 258-260
12. Kaur D., et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37 (2003) 899-909
13. Kaur D., et al. Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res. 1140 (2007) 188-194
14. Kienzl E., et al. The role of transition metals in the pathogenesis of Parkinson's disease. J. Neurol. Sci. 134 Suppl (1995) 69-78
15. Koziorowski D., et al. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control. Parkinsonism Relat. Disord. 13 (2007) 214-218
16. LaVaute T., et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27 (2001) 209-214
17. Levi S., et al. Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. Best Pract. Res. Clin. Haematol. 18 (2005) 265-276
18. Linert W., et al. Dopamine, 6-hydroxydopamine, iron, and dioxygen-their mutual interactions and possible implication in the development of Parkinson's disease. Biochim. Biophys. Acta 1316 (1996) 160-168
19. Mallajosyula J.K., et al. MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology. PLoS ONE e1616 (2008) 3
20. Mancuso M., et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J. Neuropathol. Exp. Neurol. 64 (2005) 280-294
21. McCormack A.L., et al. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93 (2005) 1030-1037
22. Monteiro H.P., and Winterbourn C.C. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem. Pharmacol. 38 (1989) 4177-4182
23. Oakley A.E., et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68 (2007) 1820-1825
24. Ortega R., et al. Iron storage within dopamine neurovesicles revealed by chemical nano-imaging. PLoS ONE e925 (2007) 2
25. Riederer P., et al. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease. Ann. Neurol. 32 Suppl (1992) S101-S104
26. Rouault T.A. Iron on the brain. Nat. Genet. 28 (2001) 299-300
27. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2 (2006) 406-414
28. Schneider B.D., and Leibold E.A. Regulation of mammalian iron homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 267-273
29. Schenck J.F., and Zimmerman E.A. High field magnetic resonance imaging of brain iron: birth of a bio marker?. NMR Biomed. 7 (2004) 433-445
30. Smith S.R., et al. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann. N.Y. Acad. Sci. 1012 (2004) 65-83
31. Thomas C.E., and Aust S.D. Release of iron from ferritin by cardiotoxic anthracycline antibiotics. Arch. Biochem. Biophys. 248 (1986) 684-689
32. Vance J.E., Karten B., and Hayashi H. Lipid dynamics in neurons. Biochem. Soc. Trans. 34 (2006) 399-403
33. Vidal R., et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J. Neuropathol. Exp. Neurol. 63 (2004) 363-380
34. Ward W.F. Protein degradation in the aging organism. Prog. Mol. Subcell Biol. 29 (2002) 35-42
35. Youdim M.B., Ben-Shachar D., and Riederer P. The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8 (1993) 1-12